X0306 4 2014-09-29 1 0001087432 INTERMUNE INC ITMN 0001024008 KABAKOFF DAVID S 3280 BAYSHORE BLVD BRISBANE CA 94005 1 0 0 0 Common stock 2014-09-29 4 U 0 21600 74.00 D 2500 D Common stock 2014-09-29 4 D 0 2500 74.00 D 0 D Restricted stock units 0.00 2014-09-29 4 D 0 7000 0.00 D Common stock 7000 0 D Stock options (right to buy) 14.41 2014-09-29 4 D 0 20000 0.00 D 2016-05-25 Common stock 20000 0 D Stock options (right to buy) 25.55 2014-09-29 4 D 0 12000 0.00 D 2017-05-15 Common stock 12000 0 D Stock options (right to buy) 15.34 2014-09-29 4 D 0 12000 0.00 D 2015-05-13 Common stock 12000 0 D Stock options (right to buy) 10.37 2014-09-29 4 D 0 12000 0.00 D 2020-05-10 Common stock 12000 0 D Stock options (right to buy) 39.46 2014-09-29 4 D 0 12000 0.00 D 2021-05-09 Common stock 12000 0 D Stock options (right to buy) 10.10 2014-09-29 4 D 0 6000 0.00 D 2022-06-03 Common stock 6000 0 D Stock options (right to buy) 9.99 2014-09-29 4 D 0 6000 0.00 D 2020-05-29 Common stock 6000 0 D Stock options (right to buy) 40.26 2014-09-29 4 D 0 8000 0.00 D 2021-05-28 Common stock 8000 0 D Pursuant to the terms of the Agreement and Plan of Merger, dated as of August 22, 2014 (the "Merger Agreement"), among InterMune, Inc. ("InterMune"), Roche Holdings, Inc. ("Roche") and Klee Acquisition Corporation, on September 29, 2014, each share of InterMune common stock, par value $0.001 ("Common Stock") tendered and accepted for payment in the Offer (as defined in the Merger Agreement) was converted into the right to receive $74.00 per share in cash, without interest (the "Merger Consideration"), subject to any required withholding taxes at the closing of the Offer. Pursuant to the terms of the Merger Agreement, on September 29, 2014, each share of Common Stock and all InterMune restricted shares issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement), other than shares of Common Stock owned by InterMune, any subsidiary of InterMune, Roche, Klee Acquisition Corporation and any other subsidiary of Roche, and shares of Common Stock owned by stockholders who have validly exercised their statutory rights of appraisal, were converted into the right to receive the Merger Consideration, subject to any required withholding taxes. Pursuant to the Merger Agreement, on September 29, 2014, each InterMune restricted stock unit subject to service-based vesting conditions outstanding immediately prior to the Effective Time was canceled and converted into the right to receive the Merger Consideration, subject to any required withholding taxes. Pursuant to the Merger Agreement, on September 29, 2014, each InterMune stock option outstanding at the Effective Time, whether or not vested, was canceled and converted into the right to receive the excess, if any, of the Merger Consideration over the exercise price per share of the stock option, subject to any required withholding taxes. By: /s/ John Hodgman, Attorney-in-fact for: David S. Kabakoff 2014-10-01